Respiratory Monitoring Devices Market by Technology (Impulse Oscillometry / Forced Oscillation Technique, Plethysmography, Spirometry), End User (Hospitals, Ambulatory Surgical Centers, Home Care, Specialty Clinics) and Forecast 2026-2034
$3,000.00
Report Specifications
Monitoring a patient’s respiratory status usually takes place in a hospital setting and may be the primary purpose for a patient being observed or admitted to a medical setting. The physical signs of respiratory distress may present as a patient appearing short of breath, having an increased work of breathing, use of their accessory muscles, and changes in skin color, general pallor, or partial or complete loss of consciousness. Technological advancement, rising respiratory disorders and geriatric population worldwide are the major factors driving the growth of the global respiratory monitoring devices market.
The global respiratory monitoring devices market report provides market size estimates ($million 2024 to 2034), market share, growth trends and forecast (CAGR% 2026 to 2034).
The global respiratory monitoring products market segmented by technology (impulse oscillometry or forced oscillation technique, plethysmography, spirometry), end user (hospitals, ambulatory surgical centers, home care, specialty clinics – physician offices and clinical laboratories), and geography.
The global respiratory monitoring devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
The global respiratory monitoring devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global respiratory monitoring devices market and included in this report are Becton, Dickinson and Company (CareFusion Corporation), CAIRE, Inc. (MGC Diagnostics Holdings, Inc.), COSMED Srl, GE Healthcare, ICU Medical, Inc. (Smiths Medical, Inc.), Masimo Corporation, Medtronic plc, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Philips Healthcare, ResMed, Inc., and Vyaire Medical, Inc.
DATA INCLUDED: Respiratory Monitoring Devices Market Size, Respiratory Monitoring Devices Market Share, Respiratory Monitoring Devices Market Growth Rates, Respiratory Monitoring Devices Market Trends, and Respiratory Monitoring Devices Market Forecast to 2034
Market Data:
- Base Year Estimation: 2025
- Historical Data Range: 2024-2025
- Forecast Period: 2026-2034
- Market Representation: Revenue in $million and CAGR % from 2026 to 2034
- Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
- Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
- Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
- Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.
Qualitative Analysis:
- Industry Overview
- Industry Trends
- Market Driver, Restraints, and Opportunities
- Market Size
- Growth Trends
- Market Profitability Analysis
- Market Attractiveness Matrix
- Competitive Landscape
- Company Overview
- Financial Performance
- Product Portfolio
- Strategic Insights
- Recent Developments
Quantitative Analysis:
- Market Size Projections: Comprehensive estimates and forecasts for all segments
- Regional Market Analysis: Estimates and forecasts for key countries
- Corporate Financial Performance: Analysis of company financials
- Competitive Landscape: Market share analysis of leading companies
For inquiries regarding discounts on single or bundled report purchases, please reach out to us.
- Introduction
- Executive Summary
- Market Size Estimation ($million, 2024-2034)
- Forecast Estimation ($million and CAGR%, 2026-2034)
- Research Methodology
- Market Landscape
- Market Dynamics
- Drivers
- Barriers
- Opportunities
- Market Share Analysis
- Companies
- Devices
- Market Trends Analysis
- Key success factors
- Market Growth Rate
- Market Attractiveness Analysis
- Market Profitability Analysis
- Buyer power
- Supplier power
- Barriers to entry
- Threat of substitute products
- Rivalry among firms in the industry
- Distribution Channels
- Market Dynamics
- Market Segmentation [refer Market Segments and Companies Tab]
- Device or Brand Type
- Diagnostic Test
- Indication Type
- Technology
- Diagnostics, Therapeutic or Surgical Application
- End User Groups
- Geography (Region, Country)
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Latin America (Brazil, Mexico, Rest of LA)
- Rest of the World (Middle East & Africa)
- Regulatory Overview
- Device Classification I, II, III, IV
- Device (FDA, EMEA) Approvals
- Company Profiles [refer Market Segments and Companies Tab]
- Company Overview
- Financial Snapshot
- Product Portfolio
- Business Strategies
- Recent Developments
- Recommendations
- References
Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What is the product or procedure volumes by country and regions?
Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)
Respiratory Monitoring Devices Market
1. Technology
1.1. Impulse Oscillometry / Forced Oscillation Technique (IOS/FOT)
1.2. Plethysmography
1.3. Spirometry
2. End User
2.1. Hospitals
2.2. Ambulatory Surgical Centers
2.3. Home Care
2.4. Specialty Clinics (physician offices and clinical laboratories)
3. Geography
3.1. North America (U.S., Canada)
3.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.3. Asia Pacific (Japan, China, India, Rest of APAC)
3.4. Latin America (Brazil, Mexico, Rest of LA)
3.5. Rest of the World
4. Company Profiles
4.1. Becton, Dickinson and Company (CareFusion Corporation)
4.2. CAIRE, Inc. (MGC Diagnostics Holdings, Inc.)
4.3. COSMED Srl
4.4. GE Healthcare
4.5. ICU Medical, Inc. (Smiths Medical, Inc.)
4.6. Masimo Corporation
4.7. Medtronic plc
4.8. ndd Medical Technologies, Inc.
4.9. Nihon Kohden Corporation
4.10. Philips Healthcare
4.11. ResMed, Inc.
4.12. Vyaire Medical, Inc.
Related Reports
-

Oxygen Therapy Devices Market and Forecast 2026-2034
$3,000.00 -

Interventional Cardiology Devices Market and Forecast 2026-2034
$3,000.00 -

Autoinjectors Market and Forecast 2026-2034
$3,000.00 -

Breast Pumps Market and Forecast 2026-2034
$3,000.00 -

Blood Pressure Monitoring Devices Market and Forecast 2026-2034
$3,000.00 -

Osteosynthesis Devices Market and Forecast 2026-2034
$3,000.00 -

Pain Management Devices Market and Forecast 2026-2034
$3,000.00 -

Respiratory Devices Market and Forecast 2026-2034
$3,000.00